Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)

Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.

NCT00295594 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.

NCT04102943 ·Status: COMPLETED ·Phase: PHASE4

Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors

NCT02608606 ·Status: COMPLETED ·Phase: NA

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

NCT00282568 ·Status: COMPLETED ·Phase: PHASE2

A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients

NCT00282256 ·Status: COMPLETED ·Phase: PHASE2

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients

NCT00384202 ·Status: COMPLETED ·Phase: PHASE3

Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

NCT00469131 ·Status: COMPLETED ·Phase: PHASE3

Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant Recipients

NCT06183892 ·Status: RECRUITING ·Phase: NA

Impact of P-gp, MRP2, ENT-1 and CNT3 on the Blood Concentration / Intra-PBMC Concentration of Tacrolimus

NCT03910868 ·Status: COMPLETED

Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients

NCT01760356 ·Status: TERMINATED

A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen

NCT02963103 ·Status: TERMINATED ·Phase: PHASE4

Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity

NCT01709136 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.

NCT00296309 ·Status: COMPLETED ·Phase: PHASE3

Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation

NCT00151632 ·Status: TERMINATED ·Phase: PHASE3

Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

NCT00717379 ·Status: COMPLETED ·Phase: PHASE4

Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients

NCT05744635 ·Status: RECRUITING

Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant Patients

NCT02337036 ·Status: UNKNOWN ·Phase: NA

Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation

NCT02877628 ·Status: COMPLETED

Tacrolimus Pharmacokinetic Subpopulations

NCT04526431 ·Status: RECRUITING

Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients

NCT00608244 ·Status: COMPLETED ·Phase: PHASE2

Extended Release Tacrolimus vs. Twice-Daily Tacrolimus

NCT03289650 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

NCT00451932 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Pharmacokinetics of Tacrolimus in Renal Recipients

NCT00411944 ·Status: COMPLETED

A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant

NCT02057484 ·Status: COMPLETED

Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus

NCT00909571 ·Status: COMPLETED ·Phase: PHASE3